Is the risk of second primary malignancy increased in multiple myeloma in the novel therapy era? A population-based, retrospective cohort study in Taiwan
Yanfang Liu
◽
Hsin-An Hou
◽
Hong Qiu
◽
Chao-Hsiun Tang
2019 ◽
Vol 8
(6)
◽
pp. 3269-3277
Lei Deng
◽
Hrönn Harðardottír
◽
Huan Song
◽
Zhengrui Xiao
◽
Changchuan Jiang
◽
...
2018 ◽
Vol 36
(15_suppl)
◽
pp. e21005-e21005
Lei Deng
◽
Zhengrui Xiao
◽
Changchuan Jiang
◽
Qian Wang
◽
Haiying Cheng
◽
...
2018 ◽
Vol 8
(6)
◽
pp. 756-762
◽
Ashwin Ganti
◽
Max A. Plitt
◽
Edward C. Kuan
◽
Hannah N. Kuhar
◽
Pete S. Batra
◽
...
1987 ◽
Vol 56
(3)
◽
pp. 349-355
◽
MP Coleman
◽
CMJ Bell
◽
P Fraser
Taewoong Choi
◽
Wooin Ahn
◽
Dong Wook Shin
◽
Kyungdo Han
◽
Dahye Kim
◽
...
2015 ◽
Vol 42
(8)
◽
pp. 1172-1178
◽
Kuan-Yin Ko
◽
Chia-Hung Kao
◽
Cheng-Li Lin
◽
Wen-Sheng Huang
◽
Ruoh-Fang Yen
Anita Feller
◽
◽
Katarina L. Matthes
◽
Andrea Bordoni
◽
Christine Bouchardy
◽
...
2017 ◽
Vol 27
(6)
◽
pp. 793-801
◽
Elena Izkhakov
◽
Micha Barchana
◽
Irena Liphshitz
◽
Barbara G. Silverman
◽
Naftali Stern
◽
...
Anita Feller
◽
◽
Katarina L. Matthes
◽
Andrea Bordoni
◽
Christine Bouchardy
◽
...
Smith Giri
◽
Peter Barth
◽
Luciano J. Costa
◽
Adam J. Olszewski
Close
Export Citation Format
Close
Share Document
Close